Analytics

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

A new laboratory will be built in Oss, while additional capacity and capabilities will be added to the Bioanalytical Center of Excellence in Assen.

Ardena Expands Bioanalytical Services in the Netherlands

Videos

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between companies, and across scientific disciplines, to work together on continuing to develop medicines to save lives.

AAPS PharmSci 360 2024: The Future of Bioanalysis

The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.

Shimadzu and UMG Göttingen Enter Analytics Collaboration

The partnership between Waters and Sartorius aims to accelerate speed and increase accuracy in bioprocessing analysis.

Waters and Sartorius Enter Partnership to Improve Bioprocessing Analysis

Aaron M. Robitaille is senior product marketing manager with Thermo Fisher Scientific.

Brandon J. Bills is product manager, Thermo Fisher Scientific.

Intelligent analytical tools detect impurities to help ensure the quality of small-molecule drug ingredients.

Stepping Up the Search for Unknown Impurities

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.

Protein Characterization Can Support Regulatory Submission

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Almac Invests in Expanding Global Biologics Testing Solutions

Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.

Shimadzu’s New LCMS-8060NX Mass Spectrometer Offers Enhanced Performance

The company is expanding its bioanalytical capacity and capabilities to support biologic drug development, cell and gene therapy development, and biomarker analysis.

Frontage Expands Bioanalytical Capacity and Capabilities

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Instrumentation advancements over the past 30 years have certainly enabled greater efficiency in pharma development and analysis despite slow adoption by the industry.


Bio/Pharmaceutical Analysis, LC-MS